Evidence map›Paper›PMID 42071147›Full record

ReviewAdvances in experimental medicine and biology2026

Key Concepts in Transcriptomics Data Analysis in the Era of Next-Gen Sequencing.

Saumya Kumar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Saumya KumarCentre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), Hannover, Germany. saumya.dileepkumar@helmholtz-hzi.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rise of next-generation sequencing technologies, gaining new insights into the molecular profiles of cells and tissues has become easier than ever. These technologies enable the investigation of the complete transcriptome, encompassing both known and unknown RNA molecules at single-base pair resolution and at much lower costs. Since comprehensive proteome measurements for biological samples remain challenging, transcriptome sequencing offers valuable insights and new avenues for exploring biological samples. These RNA-sequencing (RNA-seq) experiments generate high-throughput data, making them useful for examining unique molecular profiles alongside biological pathways and networks in various tissues and cellular subsets. Moreover, with the increasing ease of conducting single-cell transcriptomics studies, there has been a surge in large datasets, which greatly enhance our understanding of biological systems in human health and disease. In this chapter, fundamental and advanced analysis methods and concepts for both bulk and single-cell transcriptomics are discussed.

Indexed as

Gene Expression ProfilingHigh-Throughput Nucleotide SequencingTranscriptomeAnimalsHumansRNA-SeqSequence Analysis, RNASingle-Cell AnalysisSingle-Cell Gene Expression AnalysisBulk RNA-seqData analysisRNA-seqSingle-cell RNA-seqTranscriptomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.